MiniMed Group, Inc. Common Stock
MMED
Rangering i aksjer
#3401
MiniMed Group, Inc. specializes in designing, producing, and distributing a... MiniMed Group, Inc. specializes in designing, producing, and distributing a broad spectrum of medical technologies and solutions aimed at effective diabetes management. The company's diverse portfolio features essential tools like insulin pumps, continuous glucose monitoring (CGM) systems, infusion sets, specialized software platforms, and various supplementary accessories. These innovations are crafted to enable both patients and healthcare providers to accurately monitor and precisely regulate blood glucose levels. The enterprise was established in 1983 by Alfred E. Mann and is currently headquartered in Northridge, California.
Aksjekurs
$17.87
Sist synkronisert: 2026-10-21
Markedsverdi
$5.03B
Endring (1 dag)
2.14%
Endring (1 år)
-
Land
US
Handel MiniMed Group, Inc. Common Stock (MMED)
Kategori
Healthcare
P/B-forhold for MiniMed Group, Inc. Common Stock (MMED)
P/B-forhold per 2026 TTM: 0
Ifølge MiniMed Group, Inc. Common Stock sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/B-forhold (TTM) 0. Ved slutten av 2026 hadde selskapet et P/B-forhold på 0.
P/B-historikk for MiniMed Group, Inc. Common Stock fra 2023 til 2026
P/B-forhold ved hvert års slutt
| År | P/B-forhold | Endre |
|---|---|---|
| 2025 | 1.56 | 3.51% |
| 2024 | 1.51 | 0.00% |
| 2023 | 0.00 | 0.00% |
P/B-forhold for lignende selskaper eller konkurrenter
| Selskap | P/B-forhold | Forskjell i P/B-forhold | Land |
|---|---|---|---|
| 19.8228 | - |
US
|
|
| - | - |
US
|
|
| - | - |
US
|
|
| 27.8715 | - |
IL
|
|
| 3.7809 | - |
US
|
